Viruses and mitochondrial medicine: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
== News: Coronavirus - COVID-19 or 2019-nCoV == | == News: Coronavirus - COVID-19 or 2019-nCoV == | ||
[[File:COVID-19.jpg|right| | [[File:WHO-COVID-19.jpg]] | ||
[[File:COVID-19.jpg|right|300px]] | |||
:::: »'''[https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/ WHO Coronavirus disease (COVID-2019) situation reports]'''« | :::: »'''[https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/ WHO Coronavirus disease (COVID-2019) situation reports]'''« | ||
<br /> | |||
:::: 2020-03-10 '''Corona virus - University of Innsbruck: beginning with March 10, no lectures will take place on the university premises''' | :::: 2020-03-10 '''Corona virus - University of Innsbruck: beginning with March 10, no lectures will take place on the university premises''' |
Revision as of 02:11, 10 March 2020
- high-resolution terminology - matching measurements at high-resolution
Viruses and mitochondrial medicine
Description
Not enough is known about viruses and mitochondrial medicine, although several studies point towards a link between viral infection and mitochondrial dysfunction using high-resolution respirometry, with potential impact on drug development.
Abbreviation: Virus-mt-Medicine
Communicated by Gnaiger E 2020-02-23, last update 2020-03-10
- 2020-03-10 Corona virus - University of Innsbruck: beginning with March 10, no lectures will take place on the university premises
- »https://www.uibk.ac.at/newsroom/information-on-the-corona-virus.html.en«
- 2019-nCoV (WHO), SARS-CoV-2 (International Committee on Taxonomy of Viruses)
- COST: European Cooperation in Science and Technology - Statement to the COVID-19
- February 27, 2020 15:52 - Subject: Information about COST activities in the context of Coronavirus outbreak. Teresa Oliveros | Financial Controller | COST Association
- Following the communication released on Tuesday 25 February 2020, COST follows the advice of public health authorities such as the World Health Organisation (WHO) and national Ministries.
- The COST Association is fully dependent and bound to the contractual agreement with the European Commission. As per rules in this agreement, cases of force majeure will be applicable only where participants are forced to cancel their travel due to circumstances out of their control (e.g. national decisions to quarantine specific areas, block borders…). In such cases, “force majeure” will be used to cover otherwise non refundable amounts.
- Decisions to cancel travels due to fear of infection, may not be considered as force majeure.
- Should the instructions from public health authorities evolve and the European Commission (our funder) make a general decision to cover globally the current situation under force majeure, then force majeure will apply to all cancellations. This is not the case as of now.
- National authorities do provide instructions on how to handle suspicious cases. Those instructions must be followed in all cases.
- With regards to the conduct of activities in the frame of the COST Action, common sense prevails to decide to continue with an activity, to modify its venue or to postpone it. For the moment, there is no provision to suspend activities or extend period nor to carry forward unspent funding due to potential cases of COVID-19.
Publications: Viruses and mt-medicine
Year | Reference | Organism | Tissue;cell | Stress | |
---|---|---|---|---|---|
Brown 2020 BMJ | 2020 | Brown Robert A, Rhein Helga M, Alipio Mark M, Annweiler Cedric, Gnaiger Erich, Holick Michael F, Boucher Barbara J, Duque Gustavo, Féron François, Kenny Rose Anne, Montero-Odasso Manuel, Minisola Salvatore, Rhodes Jonathan, Haq Afrozul, Bejerot Susanne, Reiss Lina AJ, Zgaga Lina, Crawford Michael A, Fricker Rosemary A, Cobbold Peter, Lahore Henry W, Humble Mats B, Sarkar Amrita, Karras Spiros, Iglesias-Gonzalez Javier, Gezen-Ak Duygu, Dursun Erdinc, Cooper Isabella, Grimes David, de Voil Cedric WB (2020) COVID-19 ’ICU’ risk – 20-fold greater in the vitamin D deficient. BAME, African Americans, the older, institutionalised and obese, are at greatest risk. Sun and ‘D’-supplementation – game-changers? Research urgently required. https://doi.org/10.1136/bmj.m1548 | Human | Lung;gill Fat | |
Brown 2020 MitoFit Preprint Arch | 2020 | Brown RA, Sarkar A (2020) Vitamin D deficiency: a factor in COVID-19, progression, severity and mortality? – An urgent call for research. https://doi.org/10.26124/mitofit:200001 | Human | ||
Ledur 2020 Sci Rep | 2020 | Ledur PF, Karmirian K, Pedrosa CDSG, Souza LRQ, Assis-de-Lemos G, Martins TM, Ferreira JCCG, de Azevedo Reis GF, Silva ES, Silva D, Salerno JA, Ornelas IM, Devalle S, Madeiro da Costa RF, Goto-Silva L, Higa LM, Melo A, Tanuri A, Chimelli L, Murata MM, Garcez PP, Filippi-Chiela EC, Galina A, Borges HL, Rehen SK (2020) Zika virus infection leads to mitochondrial failure, oxidative stress and DNA damage in human iPSC-derived astrocytes. Sci Rep 10:1218. | Human | Nervous system | |
Weinstein 2019 bioRxiv | 2019 | Weinstein RN, Crawford DL (2019) Effect of EBV-transformation on oxidative phosphorylation physiology in human cell lines. bioRxiv doi: https://doi.org/10.1101/2019.12.16.878025 . | Human | Other cell lines Lymphocyte | |
Du 2019 J Virol | 2019 | Du C, Duan Y, Wang XF, Lin Y, Na L, Wang X, Chen K, Wang X (2019) Attenuation of equine lentivirus alters mitochondrial protein expression profile from inflammation to apoptosis. J Virol 93:e00653-19. | Horse | Blood cells Other cell lines | Cell death |
Braz-De-Melo 2019 Sci Rep | 2019 | Braz-De-Melo HA, Pasquarelli-do-Nascimento G, Corrêa R, das Neves Almeida R, de Oliveira Santos I, Prado PS, Picolo V, de Bem AF, Pizato N, Magalhães KG (2019) Potential neuroprotective and anti-inflammatory effects provided by omega-3 (DHA) against Zika virus infection in human SH-SY5Y cells. Sci Rep 9:20119. | Human | Neuroblastoma | |
Fernandes-Siqueira 2018 mSphere | 2018 | Fernandes-Siqueira LO, Zeidler JD, Sousa BG, Ferreira T, Da Poian AT (2018) Anaplerotic role of glucose in the oxidation of endogenous fatty acids during Dengue virus infection. mSphere 3.pii: e00458-17. | Human | Liver Other cell lines | |
Qu 2018 FASEB J | 2018 | Qu C, Zhang S, Wang W, Li M, Wang Y, van der Heijde-Mulder M, Shokrollahi E, Hakim MS, Raat NJH, Peppelenbosch MP, Pan Q (2018) Mitochondrial electron transport chain complex III sustains hepatitis E virus replication and represents an antiviral target. FASEB J 33:1008-19. | Human | Liver | |
Wang 2018 Mol Med Rep | 2018 | Wang B, Li W, Fang H, Zhou H (2018) Hepatitis B virus infection is not associated with fatty liver disease: Evidence from a cohort study and functional analysis. Mol Med Rep 19:320-26. https://doi.org/10.3892/mmr.2018.9619 | Human | Liver | |
Xia 2016 RSC Adv | 2016 | Xia Z, Yi X, Zhuang Y (2016) Stable over-expression of the human malate–aspartate NADH shuttle member Aralar I in PK15 cells improves energy metabolism and enhances proliferation of porcine circovirus-2. RSC Adv 6:61268-77. | Pig | Kidney | |
Silva 2012 PLOS ONE | 2012 | Silva da Costa L, Pereira da Silva AP, Da Poian AT, El-Bacha T (2012) Mitochondrial bioenergetic alterations in mouse neuroblastoma cells infected with Sindbis virus: implications to viral replication and neuronal death. PLoS One 7:e33871. | Mouse | Neuroblastoma | Mitochondrial disease |
El-Bacha 2012 Int J Biochem Cell Biol | 2012 | El-Bacha T, Da Poian AT (2012) Virus-induced changes in mitochondrial bioenergetics as potential targets for therapy. Int J Biochem Cell Biol 45:41-6. | Human Mouse | Nervous system Liver Fibroblast | Oxidative stress;RONS |
Morse 2012 J Infect Dis | 2012 | Morse CG, Voss JG, Rakocevic G, McLaughlin M, Vinton CL, Huber C, Hu X, Yang J, Huang da W, Logun C, Danner RL, Rangel ZG, Munson PJ, Orenstein JM, Rushing EJ, Lempicki RA, Dalakas MC, Kovacs JA (2012) HIV infection and antiretroviral therapy have divergent effects on mitochondria in adipose tissue. J Infect Dis 205:1778-1787. | Human | Skeletal muscle Blood cells Fat | |
Mutuel 2010 Virology | 2010 | Mutuel D, Ravallec M, Chabi B, Multeau C, Salmon JM, Fournier P, Ogliastro M (2010) Pathogenesis of Junonia coenia densovirus in Spodoptera frugiperda: a route of infection that leads to hypoxia. Virology 403:137-44. | Hexapods | Ischemia-reperfusion Oxidative stress;RONS | |
El-Bacha 2007 Biochim Biophys Acta | 2007 | El-Bacha T, Midlej V, Pereira da Silva AP, Silva da Costa L, Benchimol M, Galina A, Da Poian AT (2007) Mitochondrial and bioenergetic dysfunction in human hepatic cells infected with dengue 2 virus. Biochim Biophys Acta 1772:1158-66. | Human | Liver | Cell death |
Yuan 2006 Mol Cells | 2006 | Yuan X, Shan Y, Yao Z, Li J, Zhao Z, Chen J, Cong Y (2006) Mitochondrial location of severe acute respiratory syndrome coronavirus 3b protein. Mol Cells 21:186–91. | Human | Cell death | |
Vrbacky 2003 Physiol Res | 2003 | Vrbacký M, Krijt J, Drahota Z, Mĕlková Z (2003) Inhibitory effects of Bcl-2 on mitochondrial respiration. Physiol Res 52:545-54. | Human Other mammals | Endothelial;epithelial;mesothelial cell Other cell lines HeLa | Cell death |
MitoPedia concepts:
MiP concept